ENG and hepatocellular carcinoma: Previous studies have also documented expression of CD105 in both tumour (metastatic and HCC) and non-tumour bearing liver parenchyma [24–26] and put forth the view that in peri-tumoural areas its presence is perhaps indicative of a field change that predisposes to tumour progression [24].